Document Page: First | Prev | Next | All | Image | This Release | Search

File: 123096_sep96_decls23_0028.txt
Page: 0028
Total Pages: 52

Subject: DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANCE               

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: DIAGNOSIS AND TREATMENT OF DISEASES  1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS                

Document Number:          1

Folder Seq  #:         88








                                                                                                                                   RADIOS

                                                                                                  1.   Communicability:
                       2.    Obtain blood for hemoglobin, chemistry, coagula-
                             tion and culture; place IV line.                                          A.    Route: virus laden saliva of an infected animal intro-
                       3.    Perform LP if not contraindicated.                                              duced by a bite.
                       4.    Administer antibiotics:
                             a.   penicillin G, 300,000 U/kg/day divided in 8                          B.    Isolation of patients: contact il,lation for saliva
                                  to 12 doses, to a maximum of 2 million units                               and respiratory secretions. Transmission to attending
                                  Q2h IV, or                                                                 personnel has not been documented.
                             b.   if penicillin allergic: chloramphenicol 100
                                  mg/kg/day divided in 4 doses, to a maximum of                        C.    Contact prophylaxis: ont,cts ith an open wound or
                                  1 gm Q45h, IV.                                                             mucous membrane that has been exposed to the patients
                       S.    Provide hemodynamic and respiratory support as                                  saliva should receive post-exposure prophylaxis.
                             needed.
                       6.    Proceed  with more detailed history and examina-                     II.  Incubation period:     14 to 60 days (10 days to one year); 95%
                             tion; evaluate results of laboratory tests.                               are within one year.
          n.    should laboratory evaluation of CSF reveal pneumococci,                    III. Diagnosis:
                                    ,i                    r..i)@ be continued.
                               CSF reveal H. influenzae, ceftriaxone, 1 go ql2h                        A.    Symptoms and signs: nonspecific syndrome of malaise,
                                                                                                             fatigue, headache and fever lasting 2-10 days with pain
                       IV or chloramphenicol may be used.       Ampicillin 200-300                           and paraesthesia at the bite site in over 50%.         ,;yn-
                       mg/kg/day divided q6h IV (eg, 3gm IV q6h) may be used                                 drome merges to an acute encephalomyelitis with ap-
                       for H. influenzae proven sensitive to ampicilliii.                                    prehension and hyperactivity progressing to spasm of
                                                                                                             the swallowing muscles and hydrophobia.
           VII. Disposition:
                                                                                                       B.    Laboratory: diagnosis confirmed by specific fluores-
                 A.    Milder cases or cases which recover rapidly may be                                    cent antibody staining of brain tissues. No useful
                       treated at hospitals in theater in anticipation of                                    antemortem diagnostic findings that would change
                       return to duty.                                                                       management, although corneal impression smears or a
                                                                                                             skin biopsy of the neck above the bair line, stained
re, become                                      with immunofluorescent antibody, can confirm the
                       complicated, or convalesce more slowly should be                                      diagnosis.
                       evacuated after initial stabilization.
                                                                                                  IV.  Duration:
            Viii.      Prognosis: even properly treated cases may have          5-10%
                       mortality. Untreated , mortality may range from          50-                    A.    Treated: death in weeks to months.
                       85%. Residual morbidity is not unusual in properly
                       treated cases.     Hearing loss may persist.                                    B.    Untreated:    death in days to weeks following onset of
                                                                                                             clinical symptoms.
            IX.  Public health measures:
                                                                                                  V.   complications: usual multiple complications of comatose ICU
                                                                                                       patient.
                 A.    Vaccination of susceptible populations.
                                                                                                  VI.  Treatment:
                 B.    Antibiotic prophylaxis of close contacts, as above.
                                                                                                       A.    No specific anti-rabies chemotherapy available; treat-
                 C.    Prevent overcrowding in troop shelters, and provide                                   ment is directed solely at supportive care.
                       them with adequate ventilation.
re prophylaxis not indicated for routine
                                                                                                             deployment to the Middle East.

                                                                                                                                      47


                                                46

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 52 f:/Week-36/BX003203/DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS/diagnosis and treatment of diseases of importanc:12179609281524
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS
Folder Seq # = 88
Subject = DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANC
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996